StockNews.com Begins Coverage on Ionis Pharmaceuticals (NASDAQ:IONS)

StockNews.com assumed coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the stock. Other equities analysts have also recently issued reports about the company. VNET Group reiterated a maintains rating on shares of Ionis Pharmaceuticals in a report on […]

Related Keywords

United States ,Allenem Diaz , ,Insider Transactions At Ionis Pharmaceuticals ,Citigroup ,Ionis Pharmaceuticals Company Profile ,News Ratings For Ionis Pharmaceuticals Daily ,Nuveen Asset Management ,Barclays ,Ionis Pharmaceuticals Inc ,Institutional Trading Of Ionis Pharmaceuticals ,Ionis Pharmaceuticals Trading Down ,Needham Company ,Ionis Pharmaceuticals ,Analyst Recommendations For Ionis Pharmaceuticals ,Free Report ,Pharmaceuticals Trading Down ,Get Free Report ,Director Allene ,Asset Management ,Ionis Pharmaceuticals Daily ,Nasdaq Ions ,Lions ,Medical ,46433010 ,Initiated Coverage ,Stocknews Com ,